References
- Kanai M, Raz A, Goodman DS. Retinol-binding protein: the transport protein for vitamin A in human plasma. J Clin Invest 1968;47:2025-2044 https://doi.org/10.1172/JCI105889
- Blomhoff R, Green MH, Berg T, Norum KR. Transport and storage of vitamin A. Science 1990;250:399-404 https://doi.org/10.1126/science.2218545
- Feranchak AP, Gralla J, King R, Ramirez RO, Corkill M, Narkewicz MR, et al. Comparison of indices of vitamin A status in children with chronic liver disease. Hepatology 2005;42:782-792 https://doi.org/10.1002/hep.20864
- Ananian P, Hardwigsen J, Bernard D, Le Treut YP. Serum acute-phase protein level as indicator for liver failure after liver resection. Hepatogastroenterology 2005;52:857-861
- Isozaki M, Masubuchi Y, Horie T. Retinol binding protein in plasma to evaluate the hepatotoxicity of rats treated with CCl4. Res Commun Mol Pathol Pharmacol 2001;110: 303-310
- Yang Q, Graham TE, Mody N, Preitner F, Peroni OD, Zabolotny JM, et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 2005;436:356-362 https://doi.org/10.1038/nature03711
- Wu H, Jia W, Bao Y, Lu J, Zhu J, Wang R, et al. Serum retinol binding protein 4 and nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract 2008;79:185-190 https://doi.org/10.1016/j.diabres.2007.08.016
- Graham TE, Yang Q, Bluher M, Hammarstedt A, Ciaraldi TP, Henry RR, et al. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med 2006;354:2552-2563 https://doi.org/10.1056/NEJMoa054862
- Seo JA, Kim NH, Park SY, Kim HY, Ryu OH, Lee KW, et al. Serum retinol-binding protein 4 levels are elevated in non-alcoholic fatty liver disease. Clin Endocrinol (Oxf) 2008;68:555-560 https://doi.org/10.1111/j.1365-2265.2007.03072.x
- Petta S, Camma C, Di Marco V, Alessi N, Barbaria F, Cabibi D, et al. Retinol-binding protein 4: a new marker of virus-induced steatosis in patients infected with hepatitis c virus genotype 1. Hepatology 2008;48:28-37 https://doi.org/10.1002/hep.22316
- Bugianesi E, McCullough AJ, Marchesini G. Insulin resistance: a metabolic pathway to chronic liver disease. Hepatology 2005;42:987-1000 https://doi.org/10.1002/hep.20920
- Sud A, Hui JM, Farrell GC, Bandara P, Kench JG, Fung C, et al. Improved prediction of fibrosis in chronic hepatitis C using measures of insulin resistance in a probability index. Hepatology 2004;39:1239-1247 https://doi.org/10.1002/hep.20207
- Muzzi A, Leandro G, Rubbia-Brandt L, James R, Keiser O, Malinverni R, et al. Insulin resistance is associated with liver fibrosis in non-diabetic chronic hepatitis C patients. J Hepatol 2005;42:41-46 https://doi.org/10.1016/j.jhep.2004.09.022
- Afdhal NH, Nunes D. Evaluation of liver fibrosis: a concise review. Am J Gastroenterol 2004;99:1160-1174 https://doi.org/10.1111/j.1572-0241.2004.30110.x
- Wong VS, Hughes V, Trull A, Wight DG, Petrik J, Alexander GJ. Serum hyaluronic acid is a useful marker of liver fibrosis in chronic hepatitis C virus infection. J Viral Hepat 1998;5:187-192 https://doi.org/10.1046/j.1365-2893.1998.00100.x
- Imbert-Bismut F, Ratziu V, Pieroni L, Charlotte F, Benhamou Y, Poynard T. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 2001;357:1069-1075 https://doi.org/10.1016/S0140-6736(00)04258-6
- Kim CW, Yoon SK, Jo BS, Shin JY, Jang JW, Choi JY, et al. Prediction of hepatic fibrosis using serum hyaluronic acid in patients with chronic liver disease. Korean J Gastroenterol 2003;42:510-518
- Fontana RJ, Goodman ZD, Dienstag JL, Bonkovsky HL, Naishadham D, Sterling RK, et al. Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis C. Hepatology 2008;47:789-798 https://doi.org/10.1002/hep.22099
- Poynard T, Imbert-Bismut F, Ratziu V, Chevret S, Jardel C, Moussalli J, et al. Biochemical markers of liver fibrosis in patients infected by hepatitis C virus: longitudinal validation in a randomized trial. J Viral Hepat 2002;9:128-133 https://doi.org/10.1046/j.1365-2893.2002.00341.x
- Manning DS, Afdhal NH. Diagnosis and quantitation of fibrosis. Gastroenterology 2008;134:1670-1681 https://doi.org/10.1053/j.gastro.2008.03.001
- Kim MY, Baik SK, Jang YO, Suk KT, Kim JW, Kim HS, et al. Serum hyaluronic acid level: correlation with quantitative measurement of hepatic fibrosis in a cirrhotic rat model. Korean J Hepatol 2008;14:159-167 https://doi.org/10.3350/kjhep.2008.14.2.159
- Engstrom-Laurent A, Loof L, Nyberg A, Schroder T. Increased serum levels of hyaluronate in liver disease. Hepatology 1985;5:638-642 https://doi.org/10.1002/hep.1840050420
- Iloeje UH, Yang HI, Su J, Jen CL, You SL, Chen CJ. Predicting cirrhosis risk based on the level of circulating hepatitis B viral load. Gastroenterology 2006;130:678-686 https://doi.org/10.1053/j.gastro.2005.11.016
- Lee JI, Park HJ, Lee JW, Kim YS, Jeong S, Lee DH, et al. Pretreatment alanine transaminase level may not be the most important predictor of HBeAg loss in the older patient. Liver Int 2009;29:231-236 https://doi.org/10.1111/j.1478-3231.2008.01815.x
- Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology 2007;45:507-539 https://doi.org/10.1002/hep.21513
- Yagmur E, Weiskirchen R, Gressner AM, Trautwein C, Tacke F. Insulin resistance in liver cirrhosis is not associated with circulating retinol-binding protein 4. Diabetes Care 2007;30:1168-1172 https://doi.org/10.2337/dc06-2323
- Bahr MJ, Boeker KH, Manns MP, Tietge UJ. Decreased hepatic RBP4 secretion is correlated with reduced hepatic glucose production but not associated with insulin resistance in patients with liver cirrhosis. Clin Endocrinol (Oxf) 2009;70:60-65 https://doi.org/10.1111/j.1365-2265.2008.03295.x
- Newcomer ME, Ong DE. Plasma retinol binding protein: structure and function of the prototypic lipocalin. Biochim Biophys Acta 2000;1482:57-64 https://doi.org/10.1016/S0167-4838(00)00150-3
- Harrison EH, Smith JE, Goodman DS. Effects of vitamin A deficiency on the levels and distribution of retinolbinding protein and marker enzymes in homogenates and Golgi-rich fractions of rat liver. Biochim Biophys Acta 1980;628:489-497
- Ballmer PE, Walshe D, McNurlan MA, Watson H, Brunt PW, Garlick PJ. Albumin synthesis rates in cirrhosis: correlation with Child-Turcotte classification. Hepatology 1993;18:292-297 https://doi.org/10.1002/hep.1840180211
- Nelson JE, Bhattacharya R, Lindor KD, Chalasani N, Raaka S, Heathcote EJ, et al. HFE C282Y mutations are associated with advanced hepatic fibrosis in Caucasians with nonalcoholic steatohepatitis. Hepatology 2007;46:723-729 https://doi.org/10.1002/hep.21742
- Lee D, Jeong SH, Lee M, Cho YA, Kim JW, Park Y, et al. The prevalence of peripheral iron overload and the presence of HFE gene (H63D) mutation among the Korean patients with nonalcoholic fatty liver disease. Korean J Hepatol 2007;13:174-184
Cited by
- Comparative Analysis of Serum Proteomes of Moyamoya Disease and Normal Controls vol.48, pp.1, 2009, https://doi.org/10.3340/jkns.2010.48.1.8
- 간이식 환자의 뇌경색에 대한 한의학적 치료 증례보고 vol.24, pp.3, 2009, https://doi.org/10.14374/hfs.2016.24.3.225
- The Utility of Retinol-Binding Protein 4 in Predicting Liver Fibrosis in Chronic Hepatitis C Patients in Response to Direct-Acting Antivirals vol.13, pp.None, 2020, https://doi.org/10.2147/ceg.s229689
- Dynamic changes of serum protein in rats with acute intoxication of Chinese cobra snake venom by proteomic analysis vol.5, pp.4, 2009, https://doi.org/10.1080/20961790.2017.1405565
- Proteomic Analysis of Human Serum for Patients at Different Pathological Stages of Hepatic Fibrosis vol.2021, pp.None, 2009, https://doi.org/10.1155/2021/3580090